Monday, 8 February 2021

Drug Discovery Outsourcing Market to Reach $5.4 Billion by 2028

 

Drug Discovery Outsourcing Market Growth & Trends

The global drug discovery outsourcing market size is expected to reach USD 5.4 billion by 2028 registering a CAGR of 7.4% over the forecast period, according to a new report by Grand View Research, Inc. Drug discovery is a costly and lengthy process. This has forced pharmaceutical and biotech companies to opt for outsourcing their research activities to academic and private Contract Research Organizations (CROs). Thus, factors such as high R&D costs, patent expiration of best-selling drugs, and the need to speed up the drug discovery process, are expected to boost the demand for outsourcing of drug discovery in the coming years.

Rising cases of chronic diseases have compelled companies to develop better medicines. Some of the key therapeutic areas where companies are actively involved in outsourcing include oncology, cardiovascular, and anti-infectives. In November 2020, AstraZeneca collaborated with 9 of the foremost oncology medical centers to expedite research in some of the hardest-to-treat cancers. The company will be funding clinical and non-clinical research proposals from members within this network. The COVID-19 pandemic has brought pharmaceutical companies in limelight. It is demonstrating the value of drug discovery and development.

Several companies are proactively involved in developing an effective vaccine to treat the disease. Pfizer Inc. and BioNTech SE received the first approval for the vaccine following a worldwide Phase 3 trial of a potential strain to combat the virus. As for clinical trials, many of them are halted, while some are functional by adopting remote monitoring technologies. Thus, the pandemic has brought the pharmaceutical industry to center-stage, with drug discovery outsourcing becoming a key aspect to develop effective treatments against the virus. This is expected to boost the market revenue for the next 2 years i.e. a short-term boom, after which it shall regain its original growth curve.

Request a free sample copy or view report summary: Drug Discovery Outsourcing Market Report

Drug Discovery Outsourcing Market Report Highlights

  • Lead identification & candidate optimization was the dominant workflow segment of the global market in 2020
  • The segment will retain its leading position throughout the forecast period as lead identification & candidate optimization is one of the critical processes in drug discovery
  • The oncology therapeutics area segment is projected to register the fastest CAGR from 2021 to 2028
  • The small molecules drug type segment led the market in 2020 and is also projected to record the fastest growth rate during the forecast period. This, however, may change in the short term with a higher emphasis on biologics
  • In terms of revenue share, North America is estimated to be the leading regional market during the forecast period
  • However, Asia Pacific is projected to be the fastest-growing regional market from 2021 to 2028 owing to government initiatives to forge alliances with the U.S. pharmaceutical companies

Drug Discovery Outsourcing Market Segmentation

Grand View Research has segmented the global drug discovery outsourcing market on the basis of workflow, therapeutics area, drug type, and region:

Drug Discovery Outsourcing Workflow Outlook (Revenue, USD Million, 2016 - 2028)

  • Target Identification & Screening
  • Target Validation & Functional Informatics
  • Lead Identification & Candidate Optimization
  • Preclinical Development
  • Other Associated Workflow

Drug Discovery Outsourcing Therapeutics Area Outlook (Revenue, USD Million, 2016 - 2028)

  • Respiratory System
  • Pain & Anesthesia
  • Oncology
  • Ophthalmology
  • Hematology
  • Cardiovascular
  • Endocrine
  • Gastrointestinal
  • Immunomodulation
  • Anti-Infective
  • Central Nervous System
  • Dermatology
  • Genitourinary System

Drug Discovery Outsourcing Drug Type Outlook (Revenue, USD Million, 2016 - 2028)

  • Small Molecules
  • Large Molecules (Biopharmaceuticals)

Drug Discovery Outsourcing Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
  • Asia Pacific
    • Japan
    • China
  • Latin America
    • Brazil
  • MEA
    • South Africa

List of Key Players of Drug Discovery Outsourcing Market

  • Albany Molecular Research Inc.
  • EVOTEC
  • Laboratory Corporation of America Holdings
  • GenScript
  • Pharmaceutical Product Development, LLC
  • Charles River
  • WuXi AppTec
  • Merck & Co., Inc.
  • Thermo Fisher Scientific Inc.
  • Dalton Pharma Services
  • Oncodesign
  • Jubilant Biosys
  • DiscoverX Corporation
  • QIAGEN

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Real-Time Payments Market Projected to Register 33.0% CAGR from 2021 to 2028: Grand View Research Inc.

 

Real-Time Payments Market Growth & Trends

The global real-time payments market size is expected to reach USD 99.73 billion by 2028, according to a new report by Grand View Research, Inc. It is projected to register a CAGR of 33.0% from 2021 to 2028. The growing internet penetration rate and the proliferation of smartphones are expected to drive the growth of the market over the forecast period. The initiatives being pursued by various governments across the world to promote digital payments are expected to contribute to the growth.

Digital payment solution providers are putting a strong emphasis on ensuring security while making payments using smartphones and bank cards, among other payment methods. Advances in the latest technologies, such as AI and blockchain, are particularly opening opportunities for digital payment solution providers to offer efficient and secure digital payment solutions. For instance, in October 2019, SnapPay Inc. announced the launch of a new facial recognition payment technology for retail store merchants in North America.

Technology companies, such as Facebook, Amazon, WeChat, Alipay, and Google, among others, are focusing on strengthening their presence in the market for real-time payments. For instance, in December 2020, Facebook announced that it has gone live with the payments feature on the WhatsApp messaging platform in India. The initiative fell under the company’s efforts to explore new opportunities in the market.

The outbreak of the COVID-19 pandemic is anticipated to create new opportunities for the market players. Individuals are increasingly opting for contactless payment methods as part of the efforts to arrest the spread of coronavirus. The growing preference for online shopping amid the outbreak of the pandemic is also expected to propel the growth of the market over the forecast period.

Request a free sample copy or view report summary: Real-Time Payments Market Report

Real-Time Payments Market Report Highlights

  • The P2B segment is expected to continue dominating the market over the forecast period. The continued growth of e-commerce and m-commerce is expected to drive the segment growth
  • The solution segment is expected to continue dominating the market over the forecast period. The growing consumer preference for various digital payment solutions is expected to drive the growth of the segment
  • The preference for cloud-based real-time payment solutions is growing owing to their agility and the flexibility they can offer for consumers and businesses while making and receiving payments
  • The increasing number of e-commerce startups across the globe is anticipated to drive the demand for real-time payment solutions over the forecast period
  • Government bodies are increasingly deploying smart ticketing systems across various public transport systems, which is creating an opportunity for vendors of real-time payment solutions
  • Continued digitalization in emerging economies, such as China and India, is expected to create growth opportunities for vendors of real-time payments solutions in the Asia Pacific regional market

Real-Time Payments Market Segmentation

Grand View Research has segmented the global real-time payments market based on payment type, component, deployment, enterprise size, end-use industry, and region.

Real-Time Payments Payment Type Outlook (Revenue, USD Million, 2016 - 2028)

  • P2B
  • B2B
  • P2P
  • Others

Real-Time Payments Component Outlook (Revenue, USD Million, 2016 - 2028)

  • Solutions
    • Payment Gateway
    • Payment Processing
    • Security & Fraud Management
  • Services
    • Advisory Services
    • Integration & Implementation Services
    • Managed Services

Real-Time Payments Deployment Outlook (Revenue, USD Million, 2016 - 2028)

  • Cloud
  • On-premise

Real-Time Payments Enterprise Size Outlook (Revenue, USD Million, 2016 - 2028)

  • Large Enterprises
  • Small & Medium Enterprises

Real-Time Payments End-use Industry Outlook (Revenue, USD Million, 2016 - 2028)

  • Retail & E-commerce
  • BFSI
  • IT & Telecom
  • Travel & Tourism
  • Government
  • Healthcare
  • Energy & Utility
  • Others

Real-Time Payments Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
    • Mexico
  • Europe
    • UK.
    • Sweden
    • Denmark
    • Switzerland
  • Asia Pacific
    • China
    • India
    • Japan
    • Singapore
  • South America
    • Brazil
    • Argentina
  • Middle East & Africa

List of Key Players of Real-Time Payments Market

  • ACI Worldwide, Inc.
  • Mastercard Incorporated
  • Finastra
  • Visa Inc.
  • PayPal Holdings, Inc.
  • Fiserv, Inc.
  • Fidelity National Information Services, Inc. (FIS Inc.)
  • Wirecard AG
  • Worldpay, Inc.
  • Temenos AG
  • Montran Corporation
  • Volante Technologies Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Medical Device Outsourcing Market is Expected to Witness a CAGR of 11.2% over the Forecast Period

 

Medical Device Outsourcing Market Growth & Trends

The global medical device outsourcing market size is expected to reach USD 227.1 billion by 2028 registering a CAGR of 11.2%, according to a new report by Grand View Research, Inc. Rising demand for advanced medical products is the key factor fueling the market growth. Regulatory bodies are emphasizing the quality of the healthcare devices provided to the public. Thus, to meet the regulatory standards, market players are using various services like regulatory consulting. For example, the European Medical Device Regulation undertakes special spontaneous inspection of outsourced products to test the quality as well as conformity with the standards.

Contract manufacturers in developed countries like the EU nations comply with the international standards for a quality management system, which makes them a preferred option as compared to the ones in developing countries like India and China. However, the regulatory changes anticipated in the developing countries ensure compliance by contract manufacturers. Demand for regulatory compliance is expected to boost the growth of consulting services, such as remediation, compliance, and QMS, thereby contributing to the growth of the global market.

However, the current pandemic has put the MedTech industry at the center stage with unmatched demand for PPE, diagnostic tests, ventilators, and other critical supplies. Besides the ongoing extraordinary measures to promptly ramp up the manufacturing capacity & capabilities, Medtech leaders are seeking outside their boundaries of the normal sector to explore innovative solutions to supplement the capacity, such as open-source equipment design, as well as partnerships with firms outside the sector.

Request a free sample copy or view report summary: Medical Device Outsourcing Market Report

Medical Device Outsourcing Market Report Highlights

  • The contract manufacturing segment led the market in 2020 with a revenue share of 55.4% and will retain its position throughout the forecast period
  • This growth is due to the increasing trend of outsourcing by OEMs to third-party manufacturers, especially in emerging countries
  • The quality assurance services segment is projected to exhibit the fastest CAGR over the forecast period
  • Asia Pacific was the dominant regional market in 2020 owing to the easy availability of skilled human resources

Medical Device Outsourcing Market Segmentation

Grand View Research has segmented the global medical device outsourcing market on the basis of service, application, and region:

Medical Device Outsourcing Service Outlook (Revenue, USD Million, 2016 - 2028)

  • Quality Assurance Services
  • Regulatory Affairs Services
    • Clinical Trials Applications & Product Registrations
    • Regulatory Writing & Publishing
    • Legal Representation
    • Other
  • Product Design & Development Services
    • Designing & Engineering
    • Machining
    • Molding
    • Packaging
  • Product Testing & Sterilization Services
  • Product Implementation Services
  • Product Upgrade Services
  • Product Maintenance Services
  • Contract Manufacturing
    • Accessories Manufacturing
    • Assembly Manufacturing
    • Component Manufacturing
    • Device Manufacturing

Medical Device Outsourcing Application Outlook (Revenue, USD Million, 2016 - 2028)

  • Cardiology
    • Class I
    • Class II
    • Class III
  • Diagnostic Imaging
    • Class I
    • Class II
    • Class III
  • Orthopedic
    • Class I
    • Class II
    • Class III
  • IVD
    • Class I
    • Class II
    • Class III
  • Ophthalmic
    • Class I
    • Class II
    • Class III
  • General & Plastic Surgery
    • Class I
    • Class II
    • Class III
  • Drug Delivery
    • Class I
    • Class II
    • Class III
  • Dental
    • Class I
    • Class II
    • Class III
  • Endoscopy
    • Class I
    • Class II
    • Class III
  • Diabetes Care
    • Class I
    • Class II
    • Class III
  • Others
    • Class I
    • Class II
    • Class III

Medical Device Outsourcing Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • France
    • UK.
    • Germany
    • Italy
    • Spain
    • The Netherlands
    • Switzerland
    • Sweden
    • Belgium
    • Russia
  • Asia Pacific
    • Japan
    • China
    • India
    • Indonesia
    • Malaysia
    • Singapore
    • Korea
    • Thailand
    • Taiwan
    • Australia
    • Philippines
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Chile
  • Middle East & Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Israel
    • UAE
    • Egypt

List of Key Players of Medical Device Outsourcing Market

  • SGS SA
  • IQVIA
  • Toxikon, Inc.
  • Eurofins Scientific SE
  • Pace Analytical Services, Inc.
  • Intertek Group plc
  • WuXi AppTec, Inc.
  • North American Science Associates, Inc.
  • Charles River Laboratories International, Inc.
  • PAREXEL International Corp.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

U.S. E-cigarette & Vape Market to Incur Meteoric Growth During 2021 to 2028: Grand View Research Inc.

 U.S. E-cigarette & Vape Market Growth & Trends

The U.S. e-cigarette & vape market size is expected to reach USD 40.25 billion by 2028, according to a new report by Grand View Research, Inc. It is projected to register a CAGR of 27.3% from 2021 to 2028. Various factors, such as the rapid growth of vape shops in the U.S. and the increasing popularity of e-cigarettes among the youth population, is expected to drive the market growth over the forecast period. E-cigarettes and vape mods are being increasingly used by users as a substitute for smoking traditional cigarettes.

Due to the increasing health concern over the usage of conventional tobacco cigarettes, the market is expected to witness significant growth. The U.S. owns the widest e-cigarette and vape mod distribution network for sale. However, the new taxation rules among the states of the country are expected to act as potential threats to market growth during the forecast period.

Users across the globe are focusing on using personalized vaporizers. These vaporizers allow a high degree of customization by which the user can keep track of the battery strength, amount of vapor, and amount of nicotine consumed. The rapid surge in the number of available flavors that can be used to fill the cartridge is expected to drive the market growth over the forecast period.

In the U.S., the increasing usage of flavored electronic cigarettes among high school students is expected to propel the market growth. The cases of tobacco-related cancer in the U.S. are increasing. This, as a result, users are looking for alternatives to tobacco smoking, thereby driving the market growth.

Request a free sample copy or view report summary: U.S. E-cigarette & Vape Market Report

U.S. E-cigarette & Vape Market Report Highlights

  • The modular devices segment is expected to emerge as the fastest-growing segment over the forecast period as these devices are known for their high vapor production. Moreover, these devices can be constantly refilled by users
  • An increasing shift in consumer preferences from conventional smoking to e-cigarette and e-liquids is expected to drive the e-liquid segment growth over the forecast period. To make sure that e-liquids are harmless for consumption in e-cigarettes, e-liquid manufacturers are collaborating with research scientists to improve on the safety standards
  • The online distribution channel segment is expected to emerge as the fastest-growing segment over the forecast period. Numerous players across the globe are planning and executing online advertising campaigns, which catch the attention of youth since e-cigarette and vapeare growing as a trend in the extensive social media influencer community

U.S. E-cigarette & Vape Market Segmentation

Grand View Research has segmented the U.S. e-cigarette and vape market based on product, component, and distribution channel:

U.S. E-cigarette & Vape Product Outlook (Volume, Million Units; Revenue, USD Million, 2016 - 2028)

  • Disposable
  • Rechargeable
  • Modular Devices

U.S. E-cigarette & Vape Component Outlook (Volume, Million Units; Revenue, USD Million, 2016 - 2028)

  • Atomizer
  • Vape Mod
  • Cartomizer
  • E-liquid

U.S. E-cigarette & Vape Distribution Channel Outlook (Revenue, USD Million, 2016 - 2028)

  • Online
  • Retail Store
    • Convenience Stores
    • Drug Stores
    • News Stands
    • Tobacconist
    • Specialty E-cigarette Stores

List of Key Players of U.S. E-cigarette & Vape Market

  • Reynolds American Inc.
  • Imperial Brands
  • Altria Group, Inc.
  • Japan Tobacco Inc.
  • Philip Morris International
  • International Vapor Group
  • British American Tobacco
  • Nicquid
  • Shenzhen IVPS Technology Co., Ltd.
  • Shenzhen KangerTech Technology Co., Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Sunday, 7 February 2021

Brain Implants Market to Reflect a Holistic Expansion During 2021 to 2028: Grand View Research Inc.

 Brain Implants Market Growth & Trends

The global brain implants market size is anticipated to reach USD 9.2 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 9.1% from 2021 to 2028. The rise in neurological disorders such as epilepsy, Parkinson’s disease, depression, and tremors as well as growing investments in R&D to develop cost-effective brain implants is attributing to the growth of the market.

Presence of large number of population base suffering from various neurological and physiological disorders and conditions is expected to boost the demand for the implants during the forecast period. For instance, rising prevalence of Parkinson’s disease is boosting the demand for the implants as it helps in improving the movement of the body and reduces the need for drugs. As per the Parkinson’s Foundation 2016 report, over 10 million people globally are living with PD. Thus, with the increasing cases of Parkinson’s disease, the need for the implants is anticipated to grow lucratively.

In addition, technological advancement such as self-charging brain implants and memory chips is anticipated to provide the market with growth opportunities over the forecast period. For instance, in January 2020, Abbott’s Infinity DBS received an extended indication approval from the U.S. FDA for PD treatment.

Request a free sample copy or view report summary: Brain Implants Market Report

Brain Implants Market Report Highlights

  • On the basis of product type, the deep brain stimulator segment dominated the market in 2020 and accounted for the largest revenue share of 37.0% owing to rising geriatric population prone to neurological diseases coupled with growing investments in development of the stimulators
  • Based on application, the chronic pain segment dominated the market in 2020 with the share of 58.8% due to increasing prevalence of chronic pain disorders such as migraine, leg pain, and disk surgery pain. According to Migraine Research Foundation 2020, Migraine is the 3rd most prevalent neurological illness across the world, affecting 1.0 billion worldwide
  • North America dominated the market with the highest revenue share of 42.9% in 2020. This is due high prevalence of psychological disorders, availability of highly skilled physicians, and rise in awareness about treatments in this continent
  • Asia Pacific is expected to significantly lead the market in the future from 2021 to 2028 owing to increasing affordability and rising number of awareness programs about benefits of the implant

Brain Implants Market Segmentation

Grand View Research has segmented the global brain implants market on the basis of product, application, and region:

Brain Implants Product Outlook (Revenue, USD Million, 2016 - 2028)

  • Deep Brain Stimulator
  • Spinal Cord Stimulator
  • Vagus Nerve Stimulator

Brain Implants Application Outlook (Revenue, USD Million, 2016 - 2028)

  • Chronic Pain
  • Epilepsy
  • Parkinson’s Disease
  • Depression
  • Essential Tremor
  • Alzheimer’s Disease

Brain Implants Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • UK.
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
  • Latin America
    • Mexico
    • Brazil
    • Argentina
    • Colombia
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE

List of Key Players of Brain Implants Market

  • Medtronic
  • Boston Scientific Corporation
  • Jude Medical (Abbott)
  • NeuroPace, Inc.
  • Nevro Corporation
  • Synapse Biomedical Inc.
  • Aleva Neurotherapeutics SA

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Home Bedding Market Report by Opportunity, Demand, Major Driving Factors and Business Growth Strategies

 Home Bedding Market Growth & Trends

The global home bedding market size is expected to reach USD 147.09 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 9.0% from 2021 to 2028. The market is driven by the increasing consumer preference for adjustable beds, which has progressed in the lockdown caused by Covid-19 as an aid to suitably adjust the work-from-home culture. This trend has risen the penetration of customizable mattresses and bed linens, thereby boosting the market growth. Higher residential growth across regions indicating rising housing construction as well as housing permits is bound to revamp the market demand.

According to the Federal Statistical Office (Destatis), the construction of a total of 32,500 dwellings was permitted in Germany in November 2020. Compared with the corresponding period of 2019, this is an increase of 8.9% or 2,700 dwellings. However, the industry also faces significant instances of uncertainties projected by the International Sleep Products Association in 2018. For instance, the U.S. mattress industry has been affected by international trade. While imports of finished mattresses have continued to surge, their long-term significance is complicated by both higher tariffs on finished mattresses and many components, and a pending antidumping investigation on mattresses from China.

Increased consumer inclination towards working from their homes and beds has caused intermittent growth for premium and quality bedding products. According to Jerry Epperson, a mattress industry veteran and managing director of investment banking and corporate advisory firm Mann, Armistead & Epperson based in Virginia, the bedding industry enjoyed a year-over-year sales increase of more than 30% in October 2020. Moreover, the industry is benefiting from new innovations, such as high-tech adjustable bases, and interest in ancillary products sold, such as luxury pillows.

Higher traction towards designed bedrooms is linked to period dramas and active series on the OTT platforms wherein a large chunk of consumers is engaged as a cause of higher time spent indoors. One such period drama influencing a majority of consumers is Netflix’s period drama Bridgerton. It turns out that the hit series has inspired many of us to add a touch of Regency-era decor into homes. Bridgerton bedrooms alone have gained increased popularity, with an 81% increase in Google search since the show aired, according to a blog by Real Homes as of 17th January 2021. This trend has influenced consumers to adopt layering as adding a mixture of different textures and tones into a bedroom by using cushions, bedsheets, and throws is a simple way to build a luxurious feel. This scenario is likely to offer growth opportunities for the market.

Bed linens held the largest share of 31.6% in 2020. This dominance is primarily due to the increasing consumer preference for quality over brands. This has encouraged manufacturers to offer new and improved quality products with attractive designs. With the increasing preference for superior quality products, companies are focusing on introducing plant-based bed linen that claims to be softer than cotton and provides breathability and moisture control.

Request a free sample copy or view report summary: Home Bedding Market Report

Home Bedding Market Report Highlights

  • Asia Pacific is expected to register the fastest CAGR from 2021 to 2028. The regional demand for home bedding products is anticipated to grow due to the increase in the purchasing power of consumers, rising housing constructions, and growing consumer awareness regarding quality as well as sustainable bedding products
  • The offline distribution channel segment dominated the market by accounting for 68.9% share in 2020
  • By type, the bed linen segment held the largest share of 31.6% in 2020 owing to its higher penetration across households

Home Bedding Market Segmentation

Grand View Research has segmented the global home bedding market on the basis of type, distribution channel, and region:

Home Bedding Type Outlook (Revenue, USD Million, 2016 - 2028)

  • Mattress
  • Bed Linen
  • Pillows
  • Blankets
  • Others

Home Bedding Distribution Channel Outlook (Revenue, USD Million, 2016 - 2028)

  • Offline
  • Online

Home Bedding Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
  • Europe
    • Germany
    • UK.
  • Asia Pacific
    • China
    • India
  • Central & South America
    • Brazil
  • Middle East & Africa

List of Key Players of Home Bedding Market

  • Acton & Acton Ltd.
  • American Textile Company
  • Beaumont & Brown Ltd
  • Boll & Branch LLC
  • WestPoint
  • Pacific Coast Feather Company
  • Hollander
  • Portico Inc.
  • Crane & Canopy
  • Bombay Dyeing

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Laser Hair Removal Market Industry Analysis Comparing Industry Prospects And Challenges Of Investing

 Laser Hair Removal Market Growth & Trends

The global laser hair removal market size is expected to reach USD 2.8 billion by 2028 registering a CAGR of 20.6% over the forecast period, according to a new report by Grand View Research, Inc. Increasing demand for non-invasive hair removal procedures is expected to drive the market growth. Technological advancements, such as the introduction of ultra-technology, are also projected to boost the market growth.

The ultra-technology is more secure than earlier techniques and the prevalence of side-effects, such as burning sensations and temporary rashes on the skin, can be easily healed with topical applications. Asia Pacific is anticipated to register the fastest CAGR during the forecast period owing to the high prevalence of skin disorders in the emerging economies and the rise in disposable income of consumers. Moreover, growing e-commerce penetration is driving the market due to easy availability of advanced products.

The Covid-19 pandemic has created several challenges for the aesthetics industry. Initially, most of the clinics had halted their services with only emergency procedures to be performed. This has impacted the market growth. However, recently, due to ease of lockdown restrictions, services have resumed in a staggered manner with strict measures to be followed. This will boost the market growth.

Request a free sample copy or view report summary: Laser Hair Removal Market Report

Laser Hair Removal Market Report Highlights

  • The Nd:YAG laser type segment is expected to register the fastest CAGR from 2021 to 2028 owing to the high efficiency of these products on all skin types, including tanned skin, and faster repetition rates
  • The beauty clinics end-use segment is expected to lead the global market, in terms of revenue share as well as growth rate, during the forecast period owing to an increase in demand for advanced aesthetics devices for hair removal
  • The dermatology clinics segment is projected to account for a significant market share by 2028 due to the availability of skilled professionals and efficient treatments with extreme safety and comfort
  • North America was the dominant regional market in 2020 and is expected to expand further at a steady CAGR from 2021 to 2028 owing to a huge market of dermatology clinics and the adoption of innovative devices

Laser Hair Removal Market Segmentation

Grand View Research has segmented the global laser hair removal market on the basis of laser type, end-use, and region:

Laser Hair Removal Laser Type Outlook (Revenue, USD Million, 2016 - 2028)

  • Diode
  • Nd:YAG
  • Alexandrite

Laser Hair Removal End-use Outlook (Revenue, USD Million, 2016 - 2028)

  • Beauty Clinics
  • Dermatology Clinics
  • Home Use

Laser Hair Removal Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • UK.
    • France
    • Italy
    • Spain
  • Asia Pacific
    • China
    • Japan
    • India
    • Singapore
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Chile
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

List of Key Players of Laser Hair Removal Market

  • Syneron Medical Ltd.
  • Sciton, Inc.
  • Alma Lasers, Ltd.
  • Cynosure, Inc.
  • Cutera Inc.
  • Lumenis Ltd.
  • Lutronic Corp.
  • Lynton Lasers Ltd.
  • Solta Medical, Inc.
  • Strata Skin Sciences, Inc.
  • Venus Concept Canada Corp.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Facial Injectables Market Analysis by Recent Industry Developments and Regional Growth by 2028: Grand View Research Inc.

 

Facial Injectable Market Growth & Trends

The global facial injectable market size is expected to reach USD 27.7 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.8% from 2021 to 2028. The facial injectable is a substance that is used to reduce wrinkles and restore volume and fullness in the face. It is injected beneath the facial skin surface. Some commonly used facial injectables include hyaluronic acid, botulinum toxin type A, and polymer fillers.

The growing focus on physical appearance, especially in developing countries, is one of the key factors expected to drive the market. In addition, a shift in consumer preference toward minimally invasive procedures is expected to support market growth. According to the American Society of Plastic Surgeons (ASPS), in 2019, botulinum toxin A and soft tissue fillers were among the top 5 minimally invasive procedures carried out in the U.S. Thus, facial injectable holds high growth prospects in the years to come.

The Asia Pacific region is expected to serve as a key revenue-generating center. The region is backed by countries, such as India, where a growing focus on physical appearance is expected to create a lucrative opportunity for the market. Companies such as Allergan are also expanding their presence in the country owing to the rise in the middle-class population, backed by increasing disposable income.

With non-urgent and cosmetic surgeries being put on hold in most of the clinics across the world, surgeons are consulting their patients via telemedicine. Some surgeons are expecting an initial rush once the clinic reopens due to backlog cases, however, in the long run, they predict changes in the near future. There will also be an additional impact on revenue. With deep sanitization and PPEs to be worn for even injectable procedures, small businesses are expected to undergo the overhead expense and a decreased revenue, many could even shut down.

Request a free sample copy or view report summary: Facial Injectable Market Report

Facial Injectable Market Report Highlights

  • By product, the botulinum toxin type A segment led the market in 2020 and is projected to dominate throughout the forecast period. It is one of the most popularly used minimally invasive procedures
  • Based on application, the aesthetics segment is projected to be the fastest-growing segment over the forecast period owing to the rise in the use of facial injectables for aesthetic procedures, such as the treatment of wrinkles on the face
  • North America dominated the market in 2020 with a share of over 41.0% owing to the easy availability of the products and the presence of a large number of skilled surgeons

Facial Injectable Market Segmentation

Grand View Research has segmented the global facial injectable market on the basis of product, application, and region:

Facial Injectable Product Outlook (Revenue, USD Million, 2016 - 2028)

  • Collagen
  • Hyaluronic Acid (HA)
  • Botulinum Toxin Type A
  • Calcium Hydroxylapatite (CaHA)
  • Polymer Fillers
    • Polymethylmethacrylate beads (PMMA Microspheres)
    • Poly-L-Lactic Acid (PLLA)

Facial Injectable Application Outlook (Revenue, USD Million, 2016 - 2028)

  • Aesthetics
  • Therapeutics

Facial Injectable Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • UK.
    • France
    • Italy
    • Spain
    • Switzerland
    • Netherlands
    • Belgium
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
    • Malaysia
    • Singapore
    • Indonesia
    • Philippines
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Chile
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Israel
    • Turkey

List of Key Players of Facial Injectable Market

  • ALLERGAN
  • Ipse
  • Merz Pharma
  • Suneva Medical, Inc.
  • Medytox, Inc.
  • Sinclair Pharma
  • Bloomage BioTechnology Corporation Limited
  • Anika Therapeutics, Inc.
  • Prollenium Medical Technologies Inc.
  • Galderma S.A.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Digital Pathology Market Size Is Expected To Reach USD 1.5 Billion by 2028

 Digital Pathology Market Growth & Trends

The global digital pathology market size is expected to reach USD 1.5 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.8% from 2021 to 2028. The increasing prevalence of chronic diseases triggers the demand for advanced diagnostics, which is expected to drive market growth. Growing economic stability and awareness pertaining to the benefits of using Computer-Aided Diagnostics (CAD) is further contributing to the growth.

Moreover, supportive regulations amidst COVID-19 pandemic is anticipated to increase penetration of digital pathology system in coming years. A March 2020 memorandum issued by the CMS stated that laboratories would be allowed to utilize temporary testing sites, such as homes, for digital pathology review and reporting, even if they are not CLIA-certified (provided that certain criteria are met). This waiver gives pathology labs the necessary regulatory flexibility to remotely maintain operations during the pandemic.

During the pandemic, interim extraordinary measures were put in place in relation to Medical Device Single Audit Program (MDSAP) audits. These allowed substitutions of on-site audits with alternative arrangements, such as desktop audit, remote audit, hybrid audit, and surrogate audit. In July 2020, Proscia received MDSAP certification.

Digital pathology has an important role in companion diagnostics and drug development pipeline, including molecular biology, biobanking, molecular tissue profiling, and tissue microarray analysis. Increasing demand for high-quality tissue samples in tissue-based biomarker research is expected to propel the adoption of the technology over the forecast period.

Request a free sample copy or view report summary: Digital Pathology Market Report

Digital Pathology Market Report Highlights

  • Devices held the dominant market share in 2020 owing to increased use in academic research
  • The rising implementation of slide management system in stratified medicine and tissue-based biomarker research is one of the key contributing factors for the dominance of this technology
  • The software segment is expected to witness lucrative growth in the near future as the product assists in faster diagnosis and synchronization of patient data, where healthcare professionals can remotely access this information
  • Digital pathology is increasingly used in academic research owing to various benefits, such as cost-effectiveness and rapid results
  • The disease diagnosis segment is expected to witness lucrative growth over the forecast period owing to the increasing prevalence of cancer and demand for noble diagnosis techniques
  • The availability of unified platforms for workflows in pathology is anticipated to boost the usage of computer-aided imaging technology in academic research, which is anticipated to boost segment growth
  • Hospitals led the end-use segment in 2020 owing to the increasing adoption of digital pathology
  • The market is expected to remain innovation-led, with frequent acquisitions and strategic alliances. New product development and well-established distribution channels are key to the competitive advantage of leading players
  • An increasing usage rate of the digital imaging systems to facilitate faster diagnosis, particularly of chronic diseases; the increased uptake of these products serves as the key driver of this market

Digital Pathology Market Segmentation

Grand View Research has segmented the global digital pathology market on the basis of product, application, end-use, and region:

Digital Pathology Product Outlook (Revenue, USD Million, 2016 - 2028)

  • Software
  • Device
  • Storage System

Digital Pathology Application Outlook (Revenue, USD Million, 2016 - 2028)

  • Drug Discovery & Development
  • Academic research
  • Disease Diagnosis

Digital Pathology End-use Outlook (Revenue, USD Million, 2016 - 2028)

  • Hospitals
  • Biotech & pharma companies
  • Diagnostic Labs
  • Academic & research institutes

Digital Pathology Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • UK.
    • France
    • Italy
    • Spain
    • Russia
    • Netherlands
    • Switzerland
    • Sweden
  • Asia Pacific
    • Japan
    • China
    • India
    • Indonesia
    • Thailand
    • Australia
    • South Korea
    • Philippines
    • Malaysia
    • Singapore
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East and Africa (MEA)
    • Saudi Arabia
    • South Africa
    • Turkey
    • Iran
    • United Arab Emirates
    • Israel

List of Key Players of Digital Pathology Market

  • Danaher
  • Hamamatsu Photonics, Inc
  • Koninklijke Philips N.V.
  • Olympus Corporation
  • Hoffmann-La Roche Ltd
  • Mikroscan Technologies
  • Inspirata, Inc
  • Visiopharm A/S
  • Huron Digital Pathology
  • 3DHISTECH Ltd.
  • ContextVision AB

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Friday, 5 February 2021

U.S. Assisted Living Facility Market Industry Analysis , Opportunity Assessment And Forecast Till 2027: Grand View Research Inc.

 U.S. Assisted Living Facility Market Growth & Trends

The U.S. assisted living facility market size is expected to reach USD 119.2 billion by 2027, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.3% from 2021 to 2027. The rising incidence of brain injury, growing geriatric population, and technological developments are expected to boost the market growth during the forecast period.

In the U.S., the assisted living facilities (ALF) provide meals, housekeeping services, social and recreational activities, and exercise and wellness programs. They also provide medical assistance in case of an emergency. Adults opting for assisted living pay for it from their savings and investments. Community service providers, household vendors, and premium elderly homes offer the required assistance and facilities to meet the daily necessities of the elderly.

The rise in the geriatric population due to the increased life expectancy is expected to grow rapidly in the future. According to the National Institute on Aging (NIA), globally, around 8.5% of the population is aged 65 years and above. As per the data published by the Population Reference Bureau, the number of Americans aged 65 years and above is projected to reach 95 million by 2060, from 52 million in 2018; by percentage, the age group of 65 years and above is expected to increase from 16% in 2018 to 23% by 2060.

Based on the nature of the population served and service provision, residents at assisted living facilities may be at a high risk of contracting COVID-19. To cope with the situation, in March 2020, CMS released guidelines for nursing homes and ALFs to help curb the spread of the novel coronavirus. These measures include prohibitions on visitors and nonessential staff, daily monitoring for symptoms, screening employees, implementing infection control and cleaning protocols, ensuring social distancing, hiring and training additional employees, adjusting activities, and paying bonuses and overtime. The majority of these facilities were not allowed to accept new residents, and therefore, had no new revenue streams for the additional expenses associated with the virus, which is hampering the market growth.

Request a free sample copy or view report summary: U.S. Assisted Living Facility Market Report

U.S. Assisted Living Facility Market Report Highlights

  • The industry is witnessing dynamic mergers, acquisitions, and joint venture agreements. For instance, in July 2019, Kindred Healthcare, in a joint venture with Atlantic Health System, completed the construction of a 38-bed comprehensive inpatient rehabilitation facility - Atlantic Rehabilitation Institute — in Madison, NJ
  • Key players in the U.S. market for the assisted living facility are taking up initiatives, such as merger & acquisition, joint ventures, and partnerships, in order to increase their market presence
  • In August 2020, Integral Senior Living entered into a partnership with Investcor Development, along with Bow River Capital and SMC Construction, to develop a new assisted living and memory care community at Sparks, Nevada

List of Key Players of U.S. Assisted Living Facility Market

  • Atria Senior Living, Inc.
  • Kindred Healthcare, Inc.
  • Brookdale Senior Living Solutions
  • Integral Senior Living
  • Five Star Senior Living
  • Sunrise Senior Living, Inc.
  • Merrill Gardens
  • Capital Senior Living
  • Gardant Management Bradley
  • Belmont Village, L.P.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Biotechnology & Pharmaceutical Services Outsourcing Market Will Target Emerging Markets by 2028: Grand View Research Inc.

 Biotechnology & Pharmaceutical Services Outsourcing Market Growth & Trends

The global biotechnology and pharmaceutical services outsourcing market size is expected to reach USD 91.4 billion by 2028 registering a CAGR of 5.2%, according to a new report by Grand View Research, Inc. The high demand for biologics along with small molecules has led to the expansion of service portfolios of Contract Manufacturing Organizations (CMOs)/Contract Research Organizations (CROs) for biotechnology and pharmaceutical production. Small pharma/biotech companies are facing challenges while performing in-house development, regulatory affairs, product maintenance, product design & development, product testing & validation, and training & education, such as lack of substantial expertise and expensive capability. This, in turn, has created lucrative opportunities for the growth of CMOs & CROs. Contract services are growing and becoming strategic, targeted, and planned. These factors are expected to play a pivotal role in enhancing the share of CMOs/CROs in the overall market.

Growing pricing pressure, regulatory challenges, and patent expiration have led to shrinking margins in the biotech and pharmaceutical industry. Contract services offer cost saving to their clients and also help save time utilized in operations and management of a production & research facility. Furthermore, outsourcing services assist in overcoming trade barriers and facilitate the entry of firms into foreign markets. Owing to these advantages, several firms choose to outsource services rather than investing capital in production equipment and hiring skilled labor.

The coronavirus outbreak is having a considerable impact on biotech and pharma third-party service providers as well as clinical trials, resulting in trial delays, suspensions, and terminations. The global crisis has emphasized the need for virtual trials and leveraging on technology & software solutions. Increasing adoption of machine learning-based platforms & Artificial Intelligence (AI), innovative trial designs, and automation in drug manufacturing are projected to transform the CRO and CMO landscape in the coming years. Biopharmaceutical & pharmaceutical investments in novel and innovative therapies, for instance, regenerative medicine, are driving the R&D activity together with drug development services.

The biologics industry has grown substantially in recent years to include novel product types including nanobodies, rDNA, synthetic vaccines, fusion proteins, soluble receptors, immunoconjugates, and immunotherapeutics. Owing to the revolutionization of disease therapy through biologics, this sector has also provided many opportunities to explore hybrid structures that combine biologics with well-defined chemical entities. The significant growth of biologics is expected to drive the demand for outsourcing of biologics development and manufacturing.

Request a free sample copy or view report summary: Biotechnology & Pharmaceutical Services Outsourcing Market Report

Biotechnology & Pharmaceutical Services Outsourcing Market Report Highlights

  • The consulting service segment led the market in 2020 and will retain its dominant position throughout the forecast period
  • Biotechnology and pharmaceutical companies are increasingly opting for consulting services due to factors, such as the increasing number of fraudulent cases and discrepancies in intellectual property rights
  • The pharma end-use segment is expected to lead the market in terms of revenue share as well as CAGR over the forecast period as the pharma companies outsource internal activities at a larger scale due to rising pricing pressure and increasing competition
  • North America was the dominant regional market in 2020 due to the presence of biotechnology and pharmaceutical companies and the high quality of services offered by the CROs and CMOs in the region
  • However, Asia Pacific is anticipated to register the fastest CAGR over the forecast period owing to improved regulatory frameworks, the high scope for cost savings, availability of cheap labor & skilled personnel, and rapid growth of the biotechnology and pharmaceutical industry in the region

Biotechnology & Pharmaceutical Services Outsourcing Market Segmentation

Grand View Research has segmented the global biotechnology and pharmaceutical services outsourcing market on the basis of service, end-use, and region:

Biotech & Pharma Services Outsourcing Service Outlook (Revenue, USD Million, 2016 - 2028)

  • Consulting
    • Regulatory Compliance
    • Remediation
    • Quality Management Systems Consulting
    • Others
  • Auditing & Assessment
  • Regulatory Affairs
    • Clinical Trial Applications & Product Registration
    • Regulatory Writing & Publishing
    • Legal Representation
    • Others
  • Product Maintenance
  • Product Design & Development
  • Product Testing & Validation
  • Training & Education
  • Others

Biotech & Pharma Services Outsourcing End-use Outlook (Revenue, USD Million, 2016 - 2028)

  • Pharma Companies
  • Biotech Companies

Biotech & Pharma Services Outsourcing Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

List of Key Players of Biotechnology & Pharmaceutical Services Outsourcing Market

  • The Quantic Group
  • IQVIA
  • Parexel International Corp.
  • Lachman Consultant Services, Inc.
  • GMP Pharmaceuticals Pty Ltd.
  • Concept Heidelberg GmbH
  • Covance, Inc.
  • Charles River Laboratories
  • PRA Health Sciences
  • ICON plc

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Dental Implant Market Trends Regulations And Competitive Landscape Outlook to 2028

 Dental Implant Market Growth & Trends

The global dental implant market size is expected to reach USD 8.0 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 11.0% from 2021 to 2028. Rising demand for tooth replacement has provided good growth potential to the market. The increasing number of dental injuries owing to road accidents and sports injuries are some of the major factors boosting market growth.

With growing aesthetic awareness, people are exploring more treatment options, which is leading to the growth of the market. For instance, as per the American Academy of Cosmetic Dentistry data, more than 95.0% of individuals across the globe believe that their smile is a vital social asset and nearly 84.0% revealed to be under an increased pressure to perfect their smile, thus increasing the product demand. Dental implants are considered the only restorative technique that preserves and stimulates natural bone. Owing to the growing number of edentulous people, the demand for prosthetics is increasing, which is expected to be one of the major impact rendering drivers for the market.

Several industries have halted their services due to the COVID-19 pandemic. However, the dental care industry is greatly impacted by the significant decrease in elective procedures, many of which are being postponed or canceled so that hospitals can focus their resources on treating patients with COVID-19. Major Countries like the U.S and India procure raw materials and electronic components from China, which has disrupted the supply chain of much dental equipment and product manufacturers. However, with the decrease in the number of COVID-19 cases, hospitals are likely to begin scheduling elective procedures, depending on their capacity of admission and patients comfort level.

Request a free sample copy or view report summary: Dental Implant Market Report

Dental Implant Market Report Highlights

  • The titanium implant type segment held the largest market share in 2020 due to its wide applications, durability, and cost-effectiveness
  • Zirconia implants are anticipated to witness a lucrative growth rate over the forecast period due to better flexural strength, improved aesthetic appearance, and less corrosiveness as compared to titanium
  • North America dominated the market in 2020 owing to high awareness about restorative treatments and the presence of established market players

Dental Implant Market Segmentation

Grand View Research has segmented the global dental implant market on the basis of implant type and region:

Dental Implants Type Outlook (Revenue, USD Million, 2016 - 2028)

  • Titanium
  • Zirconia

Dental Implants Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • UK.
    • France
    • Italy
    • Spain
    • Sweden
    • Switzerland
    • Austria
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Iran
    • Israel
    • Turkey

List of Key Players of Dental Implant Market

  • BioHorizons IPH, Inc.
  • Nobel Biocare Services AG
  • Zimmer Biomet Holdings, Inc.
  • OSSTEM IMPLANT
  • Institut Straumann AG
  • Bicon, LLC
  • Leader Italy
  • Anthogyr SAS
  • DENTIS
  • DENTSPLY Sirona
  • DENTIUM Co., Ltd.
  • T-Plus Implant Tech. Co.
  • KYOCERA Medical Corporation

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Defibrillator Market Expected to Receive Greater Traction As Manufacturers’ Contribution Swells

 Defibrillator Market Growth & Trends

The global defibrillator market size is expected to reach USD 22.2 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.4% from 2021 to 2028. Factors contributing to the growth of this market include supportive legislative reforms, rising incidences of sudden cardiac arrests in the region, presence of integrated technology, and rising awareness for cardiac conditions. Moreover, the COVID 19 pandemic further accentuated the need for defibrillators as many elderly patients suffering from COVID-19, suffered from sudden cardiac arrests, and the device was useful for the resuscitation of such patients.

The rising demand for handling sudden cardiac arrests is leading to innovation in implantable as well as external defibrillators. Innovation with regards to implantable devices includes subcutaneous and transvenous devices, that aim to increase the comfort level of patients. Swedish Transport Agency ran a program in 2017 under the test phase, which aimed to deliver AEDs using a drone. This may reduce the delivery time of an AED, increasing the chances of survival with faster treatment. Therefore, the market is anticipated to grow because of technological advancements and product delivery innovations.

Major market players are focused on launching technologically advanced products to enhance their presence. For instance, in July 2020, Zoll Medical Corporation launched a new remote view technology feature on its X Series monitor/defibrillator. This enhanced the existing product portfolio.

Request a free sample copy or view report summary: Defibrillator Market Report

Defibrillator Market Report Highlights

  • The implantable cardioverter defibrillator segment dominated the market in terms of revenue share in 2020 and is projected to witness a CAGR of over 7.2% from 2021 to 2028. Technological advancements by market players are expected to drive segment growth
  • North America held the largest revenue share in 2020, due to the supportive healthcare infrastructure and deeper penetration of the technologically advanced devices
  • The industry participants are focusing on investing in acquisitions, collaborations, product launches, and partnerships to gain a competitive edge
  • The hospital segment held the largest revenue share of more than 91.0% in 2020 owing to the high patient footfall for treatment of their cardiovascular ailments
  • In Asia Pacific, the market is anticipated to witness a CAGR of around 8.1% owing to the presence of emerging economies such as China and India and increasing healthcare expenditure
  • In January 2020, Medtronic received the CE mark for its Crome and Cobalt portfolio of defibrillators. This significantly enhanced the company’s cardiac solutions offerings and allowed it to commercialize the products in the market

Defibrillator Market Segmentation

Grand View Research has segmented the global defibrillator market on the basis of product, end-use, and region:

Defibrillators Product Outlook (Revenue, USD Million, 2016 - 2028)

  • Implantable Cardioverter Defibrillator
    • S-ICD
    • T-ICD
      • Single Chamber
      • Dual Chamber
      • CRT-D
    • External Defibrillator
      • Manual ED
      • Automated ED
      • Wearable Cardioverter Defibrillators

Defibrillators End-use Outlook (Revenue, USD Million, 2016 - 2028)

  • Hospital
  • Pre Hospital
  • Public Access market
  • Alternate Care market
  • Home Healthcare

Defibrillators Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

List of Key Players of Defibrillator Market

  • Medtronic
  • Abbott
  • Boston Scientific Corporation
  • Stryker
  • Koninklijke Philips N.V.
  • Zoll Medical Corporation
  • Biotronik, Inc.
  • Nihon Kohden Corporation
  • Progetti Srl, Schiller
  • MS Westfalia GmbH
  • AMI Italia
  • Axion Ltd
  • Bexen Cardio

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Carbonated Soft Drink Market Will Target Emerging Markets By 2028

 Carbonated Soft Drink Market Growth & Trends

The global carbonated soft drink market size is expected to reach USD 320.1 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 4.7% from 2021 to 2028. The demand for carbonated soft drinks is influenced by an increased disposable income, customer preferences, and a growing population. The industry has numerous prominent players who are similar in size and product offerings. Many of these leaders create new product lines and actively participate in advertising wars. As numerous competitors are equally balanced, competitor rivalry is intense.

Omni-channel marketing and retailing have proved to be highly beneficial for manufacturers as they help companies leverage new tools for product launches and drive sales. Direct-to-customer is one of the most popular strategies to enhance profit margins, wherein the manufacturers would have complete control over the quality of products as well as services.

Carbonated soft drinks are being innovated in terms of taste, appearance, texture, and ingredients depending upon the target age group. Soft drinks, specially designed for children and the elderly, are usually tailored to the appropriate needs of these consumer groups and an increasing number of players catering to these two segments can be seen mushrooming in the market.

Request a free sample copy or view report summary: Carbonated Soft Drink Market Report

Carbonated Soft Drink Market Report Highlights

  • The cola flavor segment held the largest share of over 55.0% in 2020 owing to the first mover’s advantage. The citrus flavor is expected to register the fastest CAGR of 4.9% from 2021 to 2028. The industry participants are expected to increase spending on developing carbonated soft drinks fortified with citrus flavors in order to expand their reach
  • By distribution channel, the hypermarkets, supermarkets & mass merchandisers segment accounted for the largest share of more than 20.0% in 2020. A large number of consumers prefer buying these drinks from supermarkets and general merchandisers due to the shopping experience offered by these stores
  • The online stores and D2C segment is expected to remain one of the key buying mediums among buyers as a result of increasing consumers’ willingness to pay a premium for mobile and internet shopping
  • Central and South America held the largest share of over 25.0% in 2020. The young population, along with the availability of products from across the globe, is leading to a robust consumption of carbonated soft drinks in the countries, such as Brazil, Argentina, and Venezuela

Carbonated Soft Drink Market Segmentation

Grand View Research has segmented the global carbonated soft drink market on the basis of flavor, distribution channel, and region:

Carbonated Soft Drinks Flavor Outlook (Revenue, USD Billion, 2016 - 2028)

  • Cola
  • Citrus
  • Others

Carbonated Soft Drinks Distribution Channel Outlook (Revenue, USD Billion, 2016 - 2028)

  • Hypermarkets, Supermarkets & Mass Merchandisers
  • Convenience Stores & Gas Stations
  • Food Service Outlets
  • Online Stores & D2C
  • Others

Carbonated Soft Drinks Regional Outlook (Revenue, USD Billion, 2016 - 2028)

  • North America
    • US.
  • Europe
    • UK.
    • Germany
  • Asia Pacific
    • China
    • India
  • Central & South America
    • Brazil
  • Middle East & Africa
    • A.E.

List of Key Players of Carbonated Soft Drink Market

  • ANADOLU GRUBU A.Ş.
  • Danone
  • JONES SODA CO.
  • Keurig Dr Pepper Inc.
  • Monster Energy Company
  • National Beverage Corp.
  • PepsiCo
  • Refresco Group
  • SODASTREAM INTERNATIONAL LTD.
  • SUNTORY BEVERAGE & FOOD LIMITED
  • The Coca-Cola Company

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Tobacco Market Size Is Predicted To Reach A Valuation Of USD 1,073.79 Billion By 2028: Grand View Research Inc.

 Tobacco Market Growth & Trends

The global tobacco market size is expected to reach USD 1,073.79 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 1.8% from 2021 to 2028. The shifting preference among youngsters and the working-class population toward tobacco products, including cigars and next-generation products, is crucial for the market growth. Moreover, growing student spending on tobacco products across the globe is expected to offer new avenues for the growth of the market over the forecast period.

The popularity of products, such as cigarettes and cigars and cigarillos, is increasing significantly in the U.S. For instance, according to the Centers for Disease Control and Prevention, the use of tobacco and related products among the U.S. youth is growing at a steady rate. About 1 in 4 school students and 1 in 14 high school students consumed tobacco-containing products in 2018.

The consumption of tobacco products and hand-rolled cigarettes is also increasing among females in the U.S. For instance, according to the Centers for Disease Control and Prevention, in 2018, about 13.7% (nearly 34.2 million people) of the total U.S. population smoked cigarettes. Moreover, approximately 12% of the total U.S. female population aged 18 years or above, smoked cigarettes. This factor is boosting the demand for tobacco and related products in the country.

Tobacco, especially cigarette smoking, has also been increasing among women in European countries. In developed countries, tobacco usage was initially confined to men; however, tobacco usage rates among men are declining, whereas the consumption rates among women are increasing. Smoking rates among women in many European countries are close to 30–40%.

Request a free sample copy or view report summary: Tobacco Market Report

Tobacco Market Report Highlights

  • By product, the cigarettes segment held the largest share of more than 75.0% in 2020. Easy access to cigarettes at economical prices among the consumers through retail shops is expected to drive this product segment in the near future
  • The next-generation products segment is anticipated to be the fastest-growing segment with a CAGR of 2.8% from 2021 to 2028. The growing acceptance of next-generation products, including e-cigarettes, in developed economies of North America and Europe, is expected to remain a favorable factor for the segment growth
  • The Middle East and Africa is anticipated to be the fastest-growing regional market with a CAGR of 3.0% from 2021 to 2028, owing to the increasing demand for premium and next-generation tobacco products with enhanced flavors

Tobacco Market Segmentation

Grand View Research has segmented the global tobacco market on the basis of product and region:

Tobacco Product Outlook (Revenue, USD Billion, 2016 - 2028)

  • Smokeless
  • Cigarettes
  • Cigar & Cigarillos
  • Next Generation Products
  • Waterpipes
  • Others

Tobacco Regional Outlook (Revenue, USD Billion, 2016 - 2028)

  • North America
    • US.
  • Europe
    • Turkey
    • Russia
  • Asia Pacific
    • China
    • India
  • Central & South America
    • Brazil
  • Middle East & Africa
    • Egypt

List of Key Players of Tobacco Market

  • Pyxus International, Inc.
  • Swedish Match AB
  • Altria Group, Inc.
  • Korea Tobacco & Ginseng Corporation
  • Imperial Brands
  • Philip Morris International
  • British American Tobacco
  • Japan Tobacco Inc.
  • Scandinavian Tobacco Group
  • ITC Limited
  • China National Tobacco Corporation

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Patient Monitoring Accessories Market Poised to Expand at a Robust Pace Over 2033: Grand View Research Inc.

  Patient Monitoring Accessories Market Growth & Trends The global  patient monitoring accessories market  size is estimated to reach US...